Delivery Order SPE2DB24D2106-SPE2DB24FAUKW
Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,385.11 contract is for the delivery of 4565520224 ADVAIR HFA 230-21 MCG INHALER 12GM, with a completion date of August 21, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical products and medical supplies to the Department...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is valued at $2,638.06 and runs through March 22, 2024. It is not designated as a set-aside contract. The contract is for the delivery of Advair HFA 45-21 MCG inhalers, a pharmaceutical product. This award is likely part of a larger indefinite delivery vehicle (IDV) contract between DMS Pharmaceutical Group and DLA, valued...
- The Defense Logistics Agency awarded a $4,922.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 31, 2025, for the supply of Advair HFA 230-21 microgram inhalers (12 gram units). The contract, which carries an ultimate completion date of August 1, 2025, represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at approximately $500 million through November 2026. No set-aside designation was applied to this...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, with a ceiling value of $1,242.48 and a completion date of May 21, 2024. The contract is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. valued at up to $499,999,999, which allows the DLA to issue...
- This is a $16,117.61 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,062,247 units of the prescription medication Advair HFA 115-21 MCG Inhaler 12GM. The award has an ultimate completion date of April 29, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $1,715.40, is for the delivery of ADVAIR HFA 230-21 MCG INHALER 8GM, a specialized pharmaceutical product, to support the medical supply needs of military health facilities. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $1,745.46 contract is for the delivery of 4568819007 - ADVAIR HFA 230-21 MCG INHALER 12GM. The order has an ultimate completion date of July 18, 2025. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,043.10 firm fixed-price contract is for the delivery of Advair HFA 45-21 MCG Inhaler 12GM, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00. The IDC provides a comprehensive global...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The $1,249.43 award is for the delivery of ADVAIR HFA 230-21 MCG INHALER 12GM, a pharmaceutical product, and has a completion date of September 6, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,093,189 units of the prescription medication Advair HFA 115-21 MCG Inhaler 12GM. The contract has a firm fixed price of $18,298.06 and a completion date of May 1, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and...